A system and method for predicting risk of heart failure in type 2 diabetes
By using LASSO regression and SHAP analysis to screen key features and construct a machine learning model, the problem of screening for heart failure risk in type 2 diabetes patients in primary hospitals has been solved. This has enabled rapid, low-cost, and efficient screening and personalized prediction, and is suitable for primary healthcare environments in China.
CN122117349APending Publication Date: 2026-05-29JIANGSU PROVINCE HOSPITAL (THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY) +1
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU PROVINCE HOSPITAL (THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY)
- Filing Date
- 2025-12-31
- Publication Date
- 2026-05-29
Smart Images

Figure CN122117349A_ABST
Abstract
The application discloses a type 2 diabetes heart failure risk prediction system and method, and belongs to the technical field of medical diagnosis and risk assessment. The prediction system comprises the following modules: a data and feature engineering module, which is responsible for standardization processing of data and screening of key prediction factors, and obtains a core feature set for machine learning; a model construction and selection module, which uses the core feature set and trains multiple machine learning algorithms in parallel; through cross-validation and comprehensive performance evaluation, the best model is selected as a prediction model; and a model deployment and application module, which converts output results of the prediction model into a clinically usable static nomogram or online tool, and performs visual output. The application predicts by integrating clinical variables and adopting a machine learning algorithm, and provides a static nomogram and a dynamic Web application, realizes heart failure risk assessment without relying on NT-proBNP detection, and can improve the prevention and management efficiency of cardiovascular diseases.
Need to check novelty before this filing date? Find Prior Art